A mother of three was blindsided by a cervical cancer diagnosis just days before her 30th birthday — despite experiencing ...

Immuneering Corporation (IMRX), a clinical-stage oncology company, Thursday said it has signed a clinical supply agreement with ...

A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new mothers, and it has potential with other cancers as well.

Immuneering plans to evaluate IMM-1-104 in combination with Libtayo in patients with advanced non-small cell lung cancer in its ongoing Phase 2a trial – - Data presented at AACR 2023 supports ...

A new report explores the disproportionately high death rate among Black women in the Delta from cervical cancer.

A new research paper was published in Oncoscience's Volume 12 on January 20, 2025, titled "Maternal, delivery and neonatal outcomes in women with cervical cancer. A study of a population database." ...

Here are 5 important questions to ask if you’ve been told you have cervical dysplasia: ...

Angeline Usanase, 75, first learned she had cervical cancer in October 2017. When the doctor gave her the diagnosis, she couldn’t believe it. Seeking confirmation, she visited another doctor, who told ...

Regeneron's Q4 earnings report shows revenue growth, stable EYLEA sales, dividend announcement, and impressive growth for ...